Clinical Trial Update: Verapamil for Neuroprotection in Stroke [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update indicates verapamil is being studied for neuroprotection in ischemic stroke in Phase 1/Phase 2, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Verapamil (verapamil)

Snippet

Sponsor: Global Neurosciences Institute | Conditions: Ischemic Stroke | Phase 1, Phase 2 | Status: RECRUITING